The Journal of Immunology
Cure8 research brief
Why This Matters
The study identifies TRPM5 in CD4 T cells as a modulator of T cell activation and intestinal inflammation in a mouse colitis model, which could help researchers exploring new immune-pathway targets for IBD.
Who Should Pay Attention
Researchers in immunology and IBD, translational scientists studying T cell signaling, and clinicians interested in emerging mechanistic findings.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper reports that removing TRPM5 from donor CD4+CD45RB+ T cells (from TRPM5 knockout mice) and transferring them into Rag1-deficient recipient mice produced milder, delayed colitis compared with transfers using wild-type T cells.
The authors measured clinical, histologic, and immunophenotyping outcomes and observed fewer activated (CD69+) CD4 T cells and shifts toward memory and PD-1+ CD4 T cell populations in the colon when TRPM5 was absent. These findings are from an adoptive-transfer mouse model and describe mechanistic immune biology rather than a human treatment.
Keep In Mind
Findings come from an adoptive-transfer mouse model and are presented as mechanistic/basic science results in the article abstract; they are not clinical trial data and do not imply human benefit.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationThe Journal of Immunology
PublisherOxford University Press (OUP)
AuthorsJoao da Silva, José Neto, Raquel Vieira +5 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedJul 28, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Exosomes from IL-33-Stimulated Macrophages Regulate Epithelial Barrier Function to Ameliorate TNBS-Induced Colitis in Mice.
The study identifies a potential biologic approach (macrophage-derived exosomes) that improved epithelial repair and barrier function in a mouse colitis model, which could inform future therapeutic research for IBD.
TRAIL Deficiency Impairs Macrophage Differentiation and Aggravates Colitis in Mice
The study links TRAIL expression to macrophage behavior and colitis severity in mice and to higher TRAIL levels in human IBD tissue, suggesting TRAIL-related pathways could influence intestinal inflammation and might be...
Citrullination of cathepsin H promotes NETs formation and exacerbates IBD via PI3K-Akt pathway.
The study identifies a new molecular mechanism (CTSH citrullination) that appears to drive NETs formation and worsen colitis in mice, which could point toward future therapies targeting PAD4–CTSH–NETs pathways. That...